Novel Therapy Delays Muscle Atrophy In Lou Gehrigs Disease Model | Latest News RSS feed

Novel Therapy Delays Muscle Atrophy In Lou Gehrigs Disease Model - Latest News


Novel therapy delays muscle atrophy in Lou Gehrig's disease model

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study out of Case Western Reserve University School of Medicine. Researc... read more

Israeli Scientists Identify New Mechanism in ALS

A new Tel Aviv University study has identified a previously unknown mechanism involved in the development of Lou Gehrig’s disease ... virus carrying the novel miR126-5p, and found that the mice had re... read more

Gene Therapy Prolongs Survival, Slows Disease Progression in ALS Mice

report in the August 8 issue of Science that a novel gene therapy approach prolonged survival and slowed disease progression in mice with ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig' ... read more

Looking for another news?


3 Fascinating Small-Cap Biotech Stocks To Watch

It has a sound business model ... muscle activator, is in its Phase 3 under Special Protocol Assessment with the FDA. It is a potential treatment for heart failure which affects more than 6M people in ... read more

Jetpack

Changes to specific MicroRNA involved in development of Lou Gehrig's disease

A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig's disease ... a virus carrying the novel miR126-5p, and found that the mice had reco... read more

Slowing degenerative nerve disease

‘Improved motor performance' Although the treatment ... Lou Gehrig’s disease. CMT symptoms commonly include weakness of the foot and lower leg muscles, leading to a high-stepped gait with frequent tri... read more

ARMGO Pharma Receives Research Grant Award from Kennedy's Disease Association to Support Advancement of Rycal Compounds

Nov. 6, 2013 /PRNewswire/ -- ARMGO Pharma and the Kennedy's Disease Association (KDA) today announced that a research grant has been awarded to support preclinical work on novel, orally available comp... read more

US FDA grants orphan drugs status to Phytopharm's Cogane to treat ALS

Phytopharm plc announces that the United States Food & Drug Administration (US FDA) has granted Orphan Drug status to Cogane (PYM50028) for the treatment of Amyotrophic Lateral Sclerosis (ALS). ALS, a... read more

Amyotrophic lateral sclerosis (ALS) therapies market to grow by 13.5% over the next decade

Amyotrophic lateral sclerosis (ALS), sometimes called Motor Neurone Disease, or Lou Gehrig ... muscles such as those in the arms, legs, and face. ALS severely impacts physical function and manifests i... read more

Novel therapy delays muscle atrophy in Lou Gehrig's disease model

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study. Researchers found high levels of the protein -- called mitofusion ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us